NexBio Initiates Phase II Trial of DAS181 (Fludase(R)*) for Treatment of Influenza, Including Pandemic Influenza A(H1N1)

Friday, January 8, 2010 Respiratory Disease News
Email Print This Page Comment bookmark
Font : A-A+

Contact:

David Wurtman, M.D., M.B.A.

VP, Corporate Development

10665 Sorrento Valley Road

San Diego, CA  92121

Phone: (858) 452-2631

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store